PSQ Holdings 3Q 2026: Revenue $7.34M, EPS ($1) — 10-Q Summary

PSQ Holdings reported 3Q 2026 revenue of $7.34M, up 67% YoY, and a net loss of $4.13M, improved from $11.98M. Growth was driven by new product launches, higher sales, and increased interest income. Cost savings and staff reductions also contributed to the better results.

Original reporting
Published Nov 6, 2026, 11:41 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 6, 2026, 11:49 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
PSQ Holdings 3Q 2026: Revenue $7.34M, EPS ($1) — 10-Q Summary — source image
Decision brief

The 30-second read

$PSQHBullishLow
01

Why it matters

The earnings release provides the first public disclosure of these numbers, offering a fresh data point for traders.

02

Market read

Micro‑cap earnings release with modest improvements; limited but actionable for niche investors.

03

What to watch

Potential future cost cuts and staff reductions could further improve margins.

Relevance 6/10Novelty 6/10Timing: post‑market release

Background

PSQ Holdings filed its Form 10‑Q for Q3 2026, highlighting revenue growth and loss narrowing.

Company-level read

Ticker impact

$PSQHBullishMedium confidence
Context

Q3 2026 earnings released showing revenue $7.34M (+67% YoY) and net loss narrowing to $4.1M.

Expected impact

potential upward pressure as market prices in improved financials

Evidence & confidence

Revenue and loss improvements are material for a micro‑cap, but absolute numbers are small, limiting broader impact.

Market effects

Modest positive signal for niche fintech/loan‑lease segment.

Limited to US micro‑cap investors.

Low

Counterpoint

Given the small scale, the earnings improvement may be insufficient to sustain price gains.

Key entities

  • PSQ Holdings, Inc.

    Fintech firm reporting Q3 2026 results.

Related articles

$PSQHMed

PSQ Holdings Announces Third Quarter 2026 Financial Results and Reaffirms $32 Million Full-Year Revenue Outlook

PSQ Holdings, Inc. (PSQH) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 PSQ Holdings Announces Third Quarter 2026 Financial Results and Reaffirms $32 Million Full-Year Revenue Outlook · Third Quarter Revenue Grows 67% to $7.3 million; Year-to-Date Revenue More Than Doubles to $22.6 million · GAAP Operating Loss Improves 66% to $3.3 milli

$PSQHLow

PSQ Holdings, Inc. (PSQH): Completion of Acquisition or Disposition of Assets

PSQ Holdings, Inc. (PSQH) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. Exhibit 99.1 PSQ Holdings Completes Sale of EveryLife to FreeHold Brands Transaction completes the Company’s transition to a focused fintech business; proceeds to strengthen the balance sheet and fund growth initiatives BOZEMAN, Mont., -- November 5, 2026 -- PSQ Holdings, Inc. (N

$PSQHMed

PSQ Holdings Announces Second Quarter 2026 Financial Results

PSQ Holdings, Inc. (PSQH) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 PSQ Holdings Announces Second Quarter 2026 Financial Results Revenue Growth of 108% GAAP Operating Loss Improves to $4.8 Million Positive Non-GAAP Operating Income of $0.4 Million Revenue Per Headcount Improves 316% BOZEMAN, MT, July 29, 2026 — PSQ Holdings, Inc. (NY

$PSQHMed

PSQ Holdings Inc (PSQH) Q2 2026 Earnings Call Highlights: Revenue Surge and Strategic Streamlining

PSQ Holdings Inc (NYSE:PSQH) reported Q2 2026 revenue up 108% year over year, and 136% for the first half. Operating expenses fell 12% and headcount was cut about half, reducing operating cash burn 52%. Non-GAAP operating income was $0.4M versus a $2.7M loss a year ago. The company divested Every Life for $5.5M and expects growth to soften, with positive operating cash flow targeted for 2027.

$PSQHMedAI 9/10

Psq (PSQH) Q1 2026 Earnings Call Transcript

PSQ Holdings (PSQH) reported Q1 2026 revenue of $8.2 million, up 167% year over year, driven by payments and loan origination growth. Operating expenses fell 18% after restructuring, improving operating loss 34% to $6.1 million. Payments GMV rose 417% to $186.2 million; credit GMV rose 32% to $15.1 million. Cash burn fell 36% to $4.1 million; cash totaled $11.8 million. Management said AI helped efficiency and that Brands is being marketed for sale.

$CGONHigh

Why is CG Oncology stock surging today?

CG Oncology (CGON) stock rose 19.7% after Q3 2026 results showed a smaller-than-expected loss of $0.64 per share and revenue of $1.60M, both beating estimates. The company announced upcoming clinical trial data and a BLA submission, with a cash position of $984.5M. Analysts have a 'Moderate Buy' rating and $87.50 average price target.